FI982689A - 2-fenyyli-1,2-bentsoisoselenatsol-3(2H)-onin käyttö Alzheimerin taudin käsittelyyn tarkoiettujen farmaseuttisten valmisteiden valmistukseen - Google Patents

2-fenyyli-1,2-bentsoisoselenatsol-3(2H)-onin käyttö Alzheimerin taudin käsittelyyn tarkoiettujen farmaseuttisten valmisteiden valmistukseen Download PDF

Info

Publication number
FI982689A
FI982689A FI982689A FI982689A FI982689A FI 982689 A FI982689 A FI 982689A FI 982689 A FI982689 A FI 982689A FI 982689 A FI982689 A FI 982689A FI 982689 A FI982689 A FI 982689A
Authority
FI
Finland
Prior art keywords
alzheimer
phenyl
preparation
treatment
benzisoselenazole
Prior art date
Application number
FI982689A
Other languages
English (en)
Swedish (sv)
Other versions
FI982689A0 (fi
FI119622B (fi
Inventor
Iku-O Maruyama
Kazuhiro Abeyama
Hiroyuki Masayasu
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of FI982689A0 publication Critical patent/FI982689A0/fi
Publication of FI982689A publication Critical patent/FI982689A/fi
Application granted granted Critical
Publication of FI119622B publication Critical patent/FI119622B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI982689A 1996-08-27 1998-12-11 2-fenyyli-1,2-bentsoisoselenatsol-3(2H)-onin käyttö Alzheimerin taudin hoitoon tarkoitettujen farmaseuttisten valmisteiden valmistukseen FI119622B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP22551296 1996-08-27
JP22551296 1996-08-27
PCT/DE1997/000701 WO1998008511A1 (de) 1996-08-27 1997-04-07 Verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-one zur herstellung einer pharmazeutischen zubereitung für die behandlung der alzheimer-krankheit
DE9700701 1997-04-07

Publications (3)

Publication Number Publication Date
FI982689A0 FI982689A0 (fi) 1998-12-11
FI982689A true FI982689A (fi) 1998-12-11
FI119622B FI119622B (fi) 2009-01-30

Family

ID=16830487

Family Applications (1)

Application Number Title Priority Date Filing Date
FI982689A FI119622B (fi) 1996-08-27 1998-12-11 2-fenyyli-1,2-bentsoisoselenatsol-3(2H)-onin käyttö Alzheimerin taudin hoitoon tarkoitettujen farmaseuttisten valmisteiden valmistukseen

Country Status (29)

Country Link
US (1) US5948800A (fi)
EP (1) EP0826370B1 (fi)
KR (1) KR20000035859A (fi)
CN (1) CN1112922C (fi)
AT (1) ATE219361T1 (fi)
AU (2) AU3866997A (fi)
BR (1) BR9711259A (fi)
CA (1) CA2213794C (fi)
CZ (1) CZ295364B6 (fi)
DE (2) DE59707550D1 (fi)
DK (1) DK0826370T3 (fi)
EE (1) EE03953B1 (fi)
ES (1) ES2177849T3 (fi)
FI (1) FI119622B (fi)
HK (1) HK1020317A1 (fi)
HU (1) HU225264B1 (fi)
IL (1) IL127113A (fi)
LT (1) LT4602B (fi)
LV (1) LV12251B (fi)
NO (1) NO312812B1 (fi)
NZ (1) NZ332292A (fi)
PL (1) PL188481B1 (fi)
PT (1) PT826370E (fi)
SI (1) SI9720060B (fi)
TR (1) TR199700858A2 (fi)
TW (1) TW501925B (fi)
UA (1) UA59367C2 (fi)
WO (2) WO1998008511A1 (fi)
ZA (1) ZA977644B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2143898C1 (ru) * 1993-10-27 2000-01-10 Дайити Фармасьютикал Ко., Лтд. Гранулированный фармацевтический препарат и водная суспензия на его основе
JP2000016935A (ja) * 1998-07-01 2000-01-18 Dai Ichi Seiyaku Co Ltd シクロオキシゲナーゼ阻害剤
WO2000058281A1 (fr) * 1999-03-31 2000-10-05 Daiichi Pharmaceutical Co., Ltd. Substrats pour thioredoxine reductase
WO2003010154A1 (en) 2001-07-26 2003-02-06 Samsung Electronics Co. Ltd. Seleno compounds containing nitrone moiety, their preparation and their therapeutic uses
WO2003010153A1 (en) * 2001-07-26 2003-02-06 Samsung Electronics Co. Ltd. N-alkyl-n-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses
WO2003010143A1 (en) 2001-07-26 2003-02-06 Samsung Electronics Co., Ltd. Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses
GB201102248D0 (en) 2011-02-09 2011-03-23 Isis Innovation Treatment of bipolar disorder
CN103965188A (zh) * 2013-01-29 2014-08-06 中山大学 含硒多奈哌齐类似物
EP2950102A1 (en) 2014-05-30 2015-12-02 Biocross, S.L. Method for the diagnosis of alzheimer s disease and mild cognitive impairment
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
EP3067699A1 (en) 2015-03-11 2016-09-14 Neuron Bio, S.A. Method for diagnosing alzheimer's disease
PL237739B1 (pl) 2018-06-06 2021-05-17 Univ Gdanski Genisteina do zastosowania do leczenia choroby Alzheimera
CN113116888B (zh) * 2021-04-19 2022-08-26 上海兴糖生物技术有限公司 依布硒啉的用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3616923A1 (de) * 1986-05-20 1987-11-26 Nattermann A & Cie Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on
DE3638124C2 (de) * 1986-11-08 1996-09-05 Nattermann A & Cie Neue pharmazeutische Verwendung von Ebselen
JPH01131113A (ja) * 1987-08-27 1989-05-24 Dai Ichi Seiyaku Co Ltd 脳障害治療剤
JPH0238591A (ja) 1988-07-27 1990-02-07 Fujikura Ltd 高純度銅の製造方法
US5385726A (en) * 1990-08-06 1995-01-31 Rhone-Poulenc Rorer Gmbh Use of 2-phenyl-1,2-benzisoselenazol-3-(2H)-one
DE4024885C2 (de) * 1990-08-06 2002-07-18 Nattermann A & Cie Verwendung von 2-Phenyl-1,2-benzisoselenazol-3(2H)-on
FR2669633B1 (fr) * 1990-11-23 1993-01-22 Adir Nouveaux derives de la benzoselenazolinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
JPH07233056A (ja) * 1993-09-03 1995-09-05 Dai Ichi Seiyaku Co Ltd リポキシゲナーゼ阻害剤

Also Published As

Publication number Publication date
ES2177849T3 (es) 2002-12-16
NO973912L (no) 1998-03-02
CN1223580A (zh) 1999-07-21
NO973912D0 (no) 1997-08-26
HUP9903213A3 (en) 2000-12-28
AU3529897A (en) 1998-03-05
TR199700858A2 (xx) 1998-03-21
UA59367C2 (uk) 2003-09-15
LT99016A (en) 1999-10-25
EP0826370B1 (de) 2002-06-19
ZA977644B (en) 1999-02-26
CA2213794C (en) 2006-10-03
EE03953B1 (et) 2003-02-17
NZ332292A (en) 2001-07-27
AU3866997A (en) 1998-03-19
LV12251B (lv) 1999-08-20
DE19733690A1 (de) 1998-03-26
DK0826370T3 (da) 2002-10-07
CN1112922C (zh) 2003-07-02
IL127113A0 (en) 1999-09-22
SI9720060A (sl) 1999-06-30
WO1998008511A1 (de) 1998-03-05
CZ31799A3 (cs) 1999-11-17
TW501925B (en) 2002-09-11
NO312812B1 (no) 2002-07-08
WO1998008831A1 (fr) 1998-03-05
FI982689A0 (fi) 1998-12-11
FI119622B (fi) 2009-01-30
LV12251A (lv) 1999-04-20
IL127113A (en) 2003-07-06
KR20000035859A (ko) 2000-06-26
PL188481B1 (pl) 2005-02-28
DE59707550D1 (de) 2002-07-25
US5948800A (en) 1999-09-07
LT4602B (lt) 2000-01-25
SI9720060B (en) 2001-12-31
HUP9903213A1 (en) 2000-07-28
PL321796A1 (en) 1998-03-02
EE9900007A (et) 1999-06-15
PT826370E (pt) 2002-10-31
HK1020317A1 (en) 2000-04-14
AU725534B2 (en) 2000-10-12
ATE219361T1 (de) 2002-07-15
BR9711259A (pt) 1999-08-17
EP0826370A1 (de) 1998-03-04
CZ295364B6 (cs) 2005-07-13
HU225264B1 (en) 2006-08-28
CA2213794A1 (en) 1998-02-27

Similar Documents

Publication Publication Date Title
FI982689A (fi) 2-fenyyli-1,2-bentsoisoselenatsol-3(2H)-onin käyttö Alzheimerin taudin käsittelyyn tarkoiettujen farmaseuttisten valmisteiden valmistukseen
HUP0103654A2 (hu) Szmilagenin és/vagy anzurogenin-D alkalmazása Alzheimer-kór kezelésére szolgáló gyógyszerkészítmény előállítására
DK549189A (da) Galanthamin-analoge samt anvendelse af disse til fremstilling af laegemidler til behandling af alzheimer's syge
CA2191101A1 (en) Materials and methods for treatment of plaquing diseases
FI950909A (fi) Rasvahappojohdannaisia
HUP0002742A2 (hu) Mirtazapint és antipszichotikus szert tartalmazó új gyógyászati kombinációk pszichózisos rendellenességek kezelésére vagy megelőzésére
NO20001869L (no) FremgangsmÕte for behandling av Alzheimers sykdom
ZA984633B (en) Treatment of schizophrenia and psychosis
TR200000455T2 (tr) Alzheimer hastalığının tedavisinde fankinonun kullanılması.
AU3886200A (en) Methods of treating alzheimer's disease and other amyloidoses using hypericum perforatum and derivatives thereof
SE8802323D0 (sv) 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it
AU3992897A (en) Use of sulbutiamine to obtain pharmaceutical compositions useful in the treatment of certain psychomotor and psycho-intellectual disorders
DE68922596D1 (de) 3-(3-Ethyl-1,2,4-oxadiazol-5-yl)-1-azabicycloheptan, Verfahren zu seiner Herstellung und dieses enthaltende pharmazeutische Zubereitungen.
RS49595B (sr) Primena 2-fenil-1,2- benzizoselenazol-3(2h)-ona za izradu farmaceutskog preparata za lečenje alchajmerove bolesti
AU656961C (en) 1,3-oxathiolanes useful in the treatment of hepatitis
HUP9903490A3 (en) Substituted 4-(1h-benzimidazol-2-yl)[1,4]diazepanen derivatives useful for the treatment of allergic diseases, preparation and use thereof
AU2002301084A1 (en) Identification of agents for use in the treatment of alzheimer's disease
NO930083D0 (no) Sammensetning for behandling av alzheimers sykdom og fremgangsmaate for fremstilling

Legal Events

Date Code Title Description
MM Patent lapsed